Phase 1 and pharmacokinetic study of everolimus in combination with cetuximab and carboplatin for recurrent/metastatic squamous cell carcinoma of the head and neck

Publisher： Blackwell Publishing

E-ISSN： 1097-0142|120|24|3940-3951

ISSN： 0008-543X

Source： Cancer, Vol.120, Iss.24, 2014-12, pp. : 3940-3951

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cetuximab for Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck: A NICE Single Technology Appraisal

By Bagust Adrian  

PharmacoEconomics, Vol. 28, Iss. 6, 2010-06 ,pp. : 439-448

Adis International

Access to resources Recommend Favorite

Cetuximab: A Review of its Use in Squamous Cell Carcinoma of the Head and Neck and Metastatic Colorectal Cancer

By Blick Stephanie K.A.   Scott Lesley J.  

Drugs, Vol. 67, Iss. 17, 2007-01 ,pp. : 2585-2607

Adis International

Access to resources Recommend Favorite

Combination therapy with erlotinib and cisplatin is effective in patients with recurrent or metastatic squamous cell cancer of the head and neck

By  

Inpharma, Vol. 1, Iss. 1591, 2007-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

Phase II study of sunitinib malate in head and neck squamous cell carcinoma

By Choong Nicholas   Kozloff Mark   Taber David   Hu H.   Wade James   Ivy Percy   Karrison Theodore   Dekker Allison   Vokes Everett   Cohen Ezra  

Investigational New Drugs, Vol. 28, Iss. 5, 2010-10 ,pp. : 677-683

Springer Publishing Company

Access to resources Recommend Favorite

Cetuximab: A Review of its Use in Squamous Cell Carcinoma of the Head and Neck

By Frampton James E.  

Drugs, Vol. 70, Iss. 15, 2010-10 ,pp. : 1987-2010

Adis International

Access to resources Recommend Favorite